NCT00114114View on ClinicalTrials.gov

Dose-Response of Gonadal Steroids and Bone Turnover in Older Men

NACompletedINTERVENTIONAL

Enrollment

177

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions

Healthy Volunteers

Interventions

DRUG

Testosterone

Androgel placebo or 1.25, 2.5, 5. or 10\* gms topically each day

DRUG

Goserelin acetate

3.6 gms sc every 4 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (2)

All Listed Sponsors

collaborator

National Institute on Aging (NIA)

NIH

collaborator

Solvay Pharmaceuticals

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

AbbVie

INDUSTRY

lead

Massachusetts General Hospital

OTHER